Escalation of immunosuppressive therapy for inflammatory bowel disease is not associated with adverse outcomes after infection with clostridium difficile

Dana J. Lukin, Garrett Lawlor, David P. Hudesman, Laura Durbin, Jordan E. Axelrad, Monica Passi, Kimberly Cavaliere, Elliot Coburn, Michelle Loftus, Henry Jen, Alexandra Feathers, Melissa H. Rosen, Lisa B. Malter, Arun Swaminath

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Escalation of immunosuppressive therapy for inflammatory bowel disease is not associated with adverse outcomes after infection with clostridium difficile'. Together they form a unique fingerprint.

Medicine & Life Sciences